Abstract
Hyperamylasemia is frequently encountered in dialysis patients. We therefore examined the incidence of hyperamylasemia and factors affecting it in CAPD patients and hemodialysis (HD) patients. The mean serum amylase levels were 315.1±17.6mU/ml (n=42) in the CAPD patients, and 251.4±11.5mU/ml (n=60) in the HD patients. Serum amylase levels exceeded the normal range in 34 of the 42 (81.0%) CAPD patients and 38 of the 60 (63.3%) HD patients. Several analyses indicated that neither hyperlipidemia, secondary hyperparathyroidism, hypercalcemia, nor glucose intolerance had caused the hyperamylasemia in the dialysis patients. Severe hyperamylasemia in CAPD patients was observed in patients with bloody dialysates as a result of ovulation, peritonitis, antibiotic administration in dialysis fluid, pancreatic cystadenoma and chronic pancreatitis.
